Thomas Trimarchi is President and COO of BridgeBio Pharma, Inc.. Currently has a direct ownership of 377,987 shares of BBIO, which is worth approximately $8.71 Million. The most recent transaction as insider was on Nov 16, 2024, when has been sold 17,936 shares (Common Stock) at a price of $23.72 per share, resulting in proceeds of $425,441. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 378K
4.53% 3M change
n/a 12M change
Total Value Held $8.71 Million

Thomas Trimarchi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2024
SELL
Payment of exercise price or tax liability
$425,441 $23.72 p/Share
17,936 Reduced 4.53%
377,987 Common Stock
Aug 16 2024
SELL
Payment of exercise price or tax liability
$437,638 $24.4 p/Share
17,936 Reduced 4.33%
395,923 Common Stock
Aug 06 2024
BUY
Grant, award, or other acquisition
-
19,003 Added 4.39%
413,859 Common Stock
TT

Thomas Trimarchi

President and COO
Palo Alto, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO